Patent · US Active

Potassium channel inhibitors

US11098018B2 · kind B2 · utility

0Cited by
0References
31Claims
0Family size

Assignee

Inventors

Key dates

Filing dateAug 13, 2018
Grant dateAug 24, 2021
Priority date—
Expiry dateAug 13, 2038

Classification

  • Technology area (CPC A)Human Necessities
  • CPC primaryA61P9/00
  • WIPO fieldOrganic fine chemistry
  • WIPO sectorChemistry

Abstract

A compound of the general formula (I). The compounds of formula I are useful for treatment of a cardiac disease, disorder or condition in a mammal.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.